sulforaphane has been researched along with Osteosarcoma in 6 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane (SFN) has been considered a promising chemotherapeutic compound for several types of tumors by inducing apoptosis and cytostasis, but its effects (e." | 5.40 | Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. ( Costa, M; Ferreira de Oliveira, JM; Oliveira, H; Pinho, F; Pinho, S; Pinto, P; Remédios, C; Santos, C, 2014) |
| "Sulforaphane (SFN) has been considered a promising chemotherapeutic compound for several types of tumors by inducing apoptosis and cytostasis, but its effects (e." | 1.40 | Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. ( Costa, M; Ferreira de Oliveira, JM; Oliveira, H; Pinho, F; Pinho, S; Pinto, P; Remédios, C; Santos, C, 2014) |
| "Sulforaphane (SFN) is a naturally-occurring isothiocyanate best known for its role as an indirect antioxidant." | 1.40 | Sulforaphane induces oxidative stress and death by p53-independent mechanism: implication of impaired glutathione recycling. ( Almeida, L; Costa, M; Ferreira de Oliveira, JM; Oliveira, H; Pedrosa, T; Pimentel, F; Pinto, P; Remédios, C; Santos, C, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferreira de Oliveira, JM | 2 |
| Remédios, C | 2 |
| Oliveira, H | 2 |
| Pinto, P | 2 |
| Pinho, F | 1 |
| Pinho, S | 1 |
| Costa, M | 2 |
| Santos, C | 2 |
| Pedrosa, T | 1 |
| Pimentel, F | 1 |
| Almeida, L | 1 |
| Rizzo, VL | 1 |
| Levine, CB | 1 |
| Wakshlag, JJ | 1 |
| Sawai, Y | 1 |
| Murata, H | 3 |
| Horii, M | 1 |
| Koto, K | 1 |
| Matsui, T | 1 |
| Horie, N | 2 |
| Tsuji, Y | 1 |
| Ashihara, E | 1 |
| Maekawa, T | 1 |
| Kubo, T | 3 |
| Fushiki, S | 1 |
| Matsui, TA | 2 |
| Sowa, Y | 2 |
| Yoshida, T | 1 |
| Horinaka, M | 1 |
| Wakada, M | 1 |
| Nakanishi, R | 2 |
| Sakabe, T | 2 |
| Sakai, T | 2 |
6 other studies available for sulforaphane and Osteosarcoma
| Article | Year |
|---|---|
Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis.
Topics: Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Comet Assay; Cytoskeleton; DNA D | 2014 |
Sulforaphane induces oxidative stress and death by p53-independent mechanism: implication of impaired glutathione recycling.
Topics: Antioxidants; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; Glut | 2014 |
The effects of sulforaphane on canine osteosarcoma proliferation and invasion.
Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Cell Line, | 2017 |
Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; | 2013 |
Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Caspases; | 2006 |
Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bone Neoplasms; Cell Division; Cyclin-Dependent Kinase | 2007 |